Published on
December 15, 2020
- 12:00 GMT
Athenex Announces FDA Approval of Klisyri® (Tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp
Klisyri® is the first FDA approved proprietary product for Athenex First-in-class microtubule inhibitor indicated for the topical treatment of actinic keratosis (AK) on the face or scalp with a 5-day application course Klisyri will be manufactured by …
Distribution channels:
Companies, Healthcare & Pharmaceuticals Industry
...
